#Abu Dhabi #UAE #PureHealth #Healthcare Group

PureHealth's Stellar Performance in 2025

PureHealth Holding PJSC, the largest healthcare entity in the Middle East, has delivered outstanding financial results for the year ending December 31, 2025. The group reported a net profit of $550 million, marking a 17.7% growth from the previous year. Additionally, the company plans to distribute a dividend of $163 million, equivalent to around 30% of its net profit, demonstrating its strong financial health and commitment to returning value to shareholders.

Strong Revenue Growth

In FY 2025, PureHealth generated revenues of $7.4 billion, reflecting a 5.7% annual increase. This impressive growth can be attributed to robust performances in its healthcare and insurance divisions. The group's earnings before interest, taxes, depreciation, and amortization (EBITDA) rose significantly, reaching $1.3 billion, which is a 16.1% improvement year-on-year. These achievements underline the resilience of PureHealth's operational model amid the dynamic healthcare landscape.

Strategic Dividends Show Confidence

The announced dividend of $163 million will be disbursed in two equal semi-annual installments, subject to necessary approvals. This dividend policy is a clear indication of the management’s confidence in the company’s enduring earnings strength and efficient capital management practices. Chairman H.E. Kamal Al Maazmi stated that the proposed dividend reflects PureHealth’s strong balance sheet and its sustained performance across various market conditions.

Expanding Global Footprint

PureHealth has embarked on an ambitious expansion strategy, targeting both local and international markets. The group has successfully increased its footprint, with 50% of its assets now situated outside the UAE, including operations in the USA, UK, Greece, and Cyprus. The company aims to continue scaling its global network while enhancing specialized healthcare services that adapt to evolving patient needs.

Performance Across Verticals

The group's two main sectors, Care and Cover, have both shown positive momentum. In the UK, Circle Health has rebounded effectively, showing improved performance in inpatient, day-case, and outpatient services. In Greece and Cyprus, the newly acquired Hellenic Healthcare Group demonstrated substantial early success, driving significant revenue and EBITDA contributions.

Innovations in Healthcare Delivery

In addition to financial growth, PureHealth is dedicated to leveraging technology to enhance its healthcare services. The company has integrated AI capabilities into its systems, thereby improving efficiency in healthcare delivery. This focus on technological advancements is expected to set PureHealth apart in the competitive healthcare market.

Looking Ahead

As PureHealth charts its course for future growth, it aims to continue enhancing its operational capabilities and expanding its service offerings. The focus on digital solutions and AI-driven healthcare delivery is positioned to not only meet the increasing demand but also elevate the quality of care provided to patients. The group is set to achieve its goal of having international markets contribute 50% to the total revenue in the long term, demonstrating clear strategic ambition.

In conclusion, PureHealth's remarkable performance for FY 2025 highlights its strong operational model and strategic focus on growth, innovation, and shareholder value. The proposed cash dividend further solidifies the company's commitment to enhancing shareholder returns while pursuing future expansion.